Westover, Kenneth http://orcid.org/0000-0003-3653-5923
Article History
First Online: 5 March 2024
Competing interests
: K.W. serves on advisory boards for Vibliome Therapeutics, Reactive Biosciences and Velurum Therapeutics and has equity in Vibliome and Velurum. K.W. has received funding from Revolution Medicines and Astellas Pharmaceuticals. K.W. has served as a consultant for Sanofi, AstraZeneca and Amgen.